Pressure BioSciences Inc Overview
Pro stress-test →Pressure BioSciences, Inc. (OTCQB: PBIO) is a leader in the development & sale of innovative, enabling, pressure-based platform solutions for the worldwide life sciences industry. The company's products/services are based on three patented, pressure-enhanced platforms: (i) Pressure Cycling Technology ("PCT"), (ii) BaroFold Platform, and (iii) Ultra Shear Technology ("UST").
Strategic Profile
Pro stress-test →The company has installed over 300 PCT systems in approximately 200 sites worldwide. Primary development and sales efforts are in the biomarker discovery, drug discovery and design, and forensics areas. The company completed a Merger/Acquisition with Uncle Buds Hemp on January 22, 2024, expanding into consumer wellness products alongside its core laboratory instrumentation business.
Competitive Landscape
Pro stress-test →Pressure BioSciences operates in the sample preparation and enabling laboratory instrumentation space, competing indirectly with broader lab automation vendors and alternative sample prep methods used by academic and pharmaceutical research institutions. The company's pressure-based platforms differentiate through validated scientific publications and established user base, though it faces competition from both established laboratory equipment manufacturers and emerging analytical technologies.
Industry Context
Pressure BioSciences Inc operates in Laboratory Instrumentation & Enabling Technologies.
Key facts
Founded: 1978 · Headquarters: South Easton, MA · Employees: 11-50 · Revenue: ~$1.5M (TTM) · Market cap: ~$8.2M